In addition to the oncogenic mutation, high levels of inhibitor of apoptosis proteins, such as cIAP1/2, XIAP, and survivin, participate in cell death and survival by binding and inhibiting caspases, leading to radioresistance of NSCLC (120–123). Here, BIRC2 is linked to non-small cell lung carcinoma.